IP Library Patent Application 17350002
Patent Application
App. No. 17/350,002

BIOABSORBABLE POLYMERIC COMPOSITION FOR A MEDICAL DEVICE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/350,002
Abstract

A crystallized bioabsorbable polymer scaffold comprises a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold is cold-bendable.

Claims (27)

1 . A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold is cold-bendable.

2 . The bioabsorbable polymer scaffold of claim 1 , wherein the scaffold is cold bendable at temperatures in a range of about 10° C. to about 30° C.

3 . The bioabsorbable polymer scaffold of claim 1 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

4 . The bioabsorbable polymer scaffold of claim 1 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

5 . The bioabsorbable polymer scaffold of claim 1 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

6 . The bioabsorbable polymer scaffold of claim 1 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

7 . The bioabsorbable polymer scaffold of claim 1 , wherein the composition includes amorphous and semicrystalline polymer portions.

8 . The bioabsorbable polymer scaffold of claim 7 , wherein a crystallinity and tensile strength of the composition is adjustable by elongation of the semicrystalline portion.

9 . The bioabsorbable polymer scaffold of claim 1 , further comprising at least one radiopaque marker.

10 . A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) in the form of block copolymers of blocky copolymers, wherein the scaffold crystallizes in response to orthogonal strain.

11 . The bioabsorbable polymer scaffold of claim 10 , wherein the scaffold includes struts that orient and crystallize in response to orthogonal strain upon deployment.

12 . The bioabsorbable polymer scaffold of claim 10 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

13 . The bioabsorbable polymer scaffold of claim 10 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

14 . The bioabsorbable polymer scaffold of claim 10 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

15 . The bioabsorbable polymer scaffold of claim 10 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

16 . The bioabsorbable polymer scaffold of claim 10 , wherein the composition includes amorphous and semicrystalline polymer portions.

17 . The bioabsorbable polymer scaffold of claim 10 , further comprising at least one radiopaque marker.

18 . A crystallized bioabsorbable polymer scaffold comprising a polymer composition of poly (L-lactide-co-tri-methylene-carbonate) or poly (D-lactide-co-tri-methylene-carbonate) or poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone) wherein a contaminant monomeric residual fraction in the scaffold does not exceed about 0.5%.

19 . The bioabsorbable polymer scaffold of claim 18 , wherein contaminant monomeric residual fraction in the scaffold does not exceed about 0.3%.

20 . The bioabsorbable polymer scaffold of claim 18 , wherein contaminant monomeric residual fraction in the scaffold does not exceed about 0.2%.

21 . The bioabsorbable polymer scaffold of claim 18 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone) or poly (D-lactide-co-ε-caprolactone).

22 . The bioabsorbable polymer scaffold of claim 18 , wherein the polymer composition comprises poly (L-lactide-co-ε-caprolactone).

23 . The bioabsorbable polymer scaffold of claim 18 , further comprising a poly (L-lactide) moiety or a poly (D-lactide) moiety or a poly L-lactide-co-PEG moiety or a poly D-lactide-co-PEG moiety.

24 . The bioabsorbable polymer scaffold of claim 18 , wherein the composition includes increased hydrophilicity and free molecular volume allowing for uptake of water.

25 . The bioabsorbable polymer scaffold of claim 18 , wherein the composition includes amorphous and semicrystalline polymer portions.

26 . The bioabsorbable polymer scaffold of claim 25 , wherein a crystallinity and tensile strength of the composition is adjustable by elongation of the semicrystalline portion.

27 . The bioabsorbable polymer scaffold of claim 18 , further comprising at least one radiopaque marker.

Assignments (2)
CHANGE OF ADDRESS Recorded Jun 15, 2022
From: ORBUSNEICH MEDICAL PTE. LTD.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 060386/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2021
From: THATCHER, G. LAWRENCE; COTTONE, ROBERT J.
To: ORBUSNEICH MEDICAL PTE. LTD.
Reel/Frame 056570/0633 →